Pages that link to "Q41385819"

The following pages link to Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine (Q41385819):

Displaying 21 items.

• Three year naturalistic outcome study of panic disorder patients treated with paroxetine (Q24797730) (← links)
• Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetine (Q33756416) (← links)
• Short- and long-term functional consequences of fluoxetine exposure during adolescence in male rats. (Q33843546) (← links)
• Fluoxetine in panic disorder: pharmacologic and tritiated platelet imipramine and paroxetine binding study (Q33921564) (← links)
• 5-HT1A partial agonists. What is their future? (Q36636744) (← links)
• Overview of panic disorder. (Q36647657) (← links)
• Influence of sex and corticotropin-releasing factor pathways as determinants in serotonin sensitivity (Q37281171) (← links)
• Serotonin selectivity for obsessive compulsive and panic disorders (Q37423109) (← links)
• Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder (Q37905571) (← links)
• Antidepressants and benzodiazepines for panic disorder in adults. (Q38952014) (← links)
• A risk-benefit assessment of pharmacological treatments for panic disorder (Q39447018) (← links)
• 5-HT1A receptor-effector system responsivity in panic disorder (Q41089166) (← links)
• Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin (Q41137331) (← links)
• Experimental anxiety and antidepressant drugs: the effects of moclobemide, a selective reversible MAO-A inhibitor, fluoxetine and imipramine in mice (Q42641727) (← links)
• Biphasic effects of selective serotonin reuptake inhibitors on anxiety: rapid reversal of escitalopram's anxiogenic effects in the novelty-induced hypophagia test in mice? (Q47787195) (← links)
• MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine. A double blind placebo controlled study (Q48880046) (← links)
• Serotonin function in panic disorder: effect of 1-5-hydroxytryptophan in patients and controls (Q51183120) (← links)
• Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs. (Q52211597) (← links)
• The ambivalent behaviour "stretched approach posture" in the rat as a paradigm to characterize anxiolytic drugs (Q70831122) (← links)
• Effects of the 5-HT1A receptor agonist flesinoxan in panic disorder (Q71719902) (← links)
• Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine (Q72561763) (← links)